Nisa Investment Advisors’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Buy
3,870
+756
+24% +$41K ﹤0.01% 1176
2025
Q4
$144K Sell
3,114
-140
-4% -$6.26K ﹤0.01% 1320
2025
Q3
$117K Buy
3,254
+1,596
+96% +$52.9K ﹤0.01% 1385
2025
Q2
$53.9K Sell
1,658
-1,319
-44% -$43.2K ﹤0.01% 1569
2025
Q1
$112K Buy
2,977
+293
+11% +$23.4K ﹤0.01% 1366
2024
Q4
$220K Buy
2,684
+475
+22% +$47.2K ﹤0.01% 1268
2024
Q3
$252K Buy
2,209
+110
+5% +$9.91K ﹤0.01% 1223
2024
Q2
$158K Buy
2,099
+825
+65% +$56.2K ﹤0.01% 1369
2024
Q1
$87K Buy
1,274
+85
+7% +$5.89K ﹤0.01% 1508
2023
Q4
$74.7K Sell
1,189
-1,192
-50% -$61.9K ﹤0.01% 1523
2023
Q3
$121K Hold
2,381
﹤0.01% 1446
2023
Q2
$119K Buy
2,381
+669
+39% +$31.7K ﹤0.01% 1467
2023
Q1
$64K Sell
1,712
-54,940
-97% -$2.33M ﹤0.01% 1639
2022
Q4
$2.72M Buy
56,652
+55,820
+6,709% +$2.19M 0.02% 638
2022
Q3
$35K Buy
832
+41
+5% +$1.04K ﹤0.01% 1875
2022
Q2
$17K Sell
791
-739
-48% -$17.1K ﹤0.01% 2085
2022
Q1
$37K Hold
1,530
﹤0.01% 1920
2021
Q4
$29K Buy
+1,530
New +$35.6K ﹤0.01% 1859

Other funds holding PCVX